Why BioMarin Pharmaceutical Stock Topped the Market on Tuesday

Key Points The biotech published its latest set of quarterly results. It posted a surprise net profit for the period. 10 stocks we like better than BioMarin Pharmaceutical › BioMarin Pharmaceutical (NASDAQ: BMRN) reported its third-quarter earnings after market close Monday, and they were good enough to push the biotech stock almost 2% higher the following day. With that performance, the shares notched a slight beat on the bellwether S&P 500 index, which ticked up by 1.2%. Surprise, surprise For t ...